Delivery Order SPE2DB22D1103-SPE2DB25FH1Q2
- Not listed
- The Defense Logistics Agency awarded a $15,537.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream on November 20, 2025, with completion targeted for November 21, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $8.3K delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream on August 4, 2025, with completion targeted for August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a $51,004.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Opzelura 1.5% cream (60 grams). This is a non-set-aside contract with an ultimate completion date of August 21, 2025, and represents a delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,073.05 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Opzelura 1.5% Cream in 60-gram units. This firm fixed-price delivery order, with an ultimate completion date of April 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical vendor that serves military...
- The Defense Logistics Agency awarded a $10,052.61 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Opzelura 1.5% cream in 60-gram quantities. This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,031.11 to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream on April 22, 2025, with completion scheduled for April 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction under DLA's medical procurement operations, which...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.37 to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, a topical pharmaceutical product. This non-set-aside, firm fixed price delivery order was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order represents a...
- The Defense Logistics Agency awarded a $3,055.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a $7,999.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, with an ultimate completion date of November 17, 2025. This non-competitive, non-set-aside award represents a child delivery order under AmerisourceBergen's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,381.02 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in a 60-gram quantity. This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH1Q2Delivery Order
The Defense Logistics Agency awarded a $25.4K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 grams of Opzelura 1.5% cream, with a completion date of September 8, 2025. This is a non-set-aside competitive award issued to the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M vehicle valued through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. The company maintains a substantial portfolio of federal pharmaceutical contracts covering diverse therapeutic domains including specialty medications, vaccines, and medical supplies. The DLA continues to work with multiple contractors under its Pharmaceutical Prime Vendor Global Program framework to ensure robust supply chain capabilities across different regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.4k | 9/5/25 |